NEW BRUNSWICK, N.J. – November 16, 2026 – Johnson & Johnson today announced that the U.S. Food and Drug Administration has cleared an expanded otorhinolaryngology, or ENT, indication for HARMONIC 1100 Shears. The indication enables use in ENT procedures involving pediatric and adult patients for the ligation and division of vessels, lymphatics and tissue bundles. This is the first Johnson & Johnson ultrasonic device with a 7 mm vessel sealing indication for ENT procedures and is designed to deliver minimal thermal spread,1-7 supporting the precise tissue management required in these types of procedures.
Supporting ENT Procedures
HARMONIC 1100 Shears is a sterile, single-patient-use advanced ultrasonic energy device for general dissection, vessel sealing, back-scoring, otomy creation, mesentery marching or meticulous tissue plane dissection. Its ergonomic handle, integrated handpiece and Advanced Hemostasis technology include dual energy-delivery buttons for focused dissection or coagulation.4
ENT procedures often require precise dissection and tissue preservation, particularly in pediatric patients and other anatomically sensitive structures. HARMONIC devices use heat to seal and divide vessels with minimal lateral thermal spread,1-7 and the curved, tapered blade of HARMONIC 1100 Shears mirrors a mechanical dissector,8-12* designed to enable precise access to tissue planes in the deep, tight spaces encountered during ENT procedures. 11,13†
Evidence Supporting the Clearance
The expanded indication was supported by real-world evidence from the Premier Healthcare Database showing low 30-day complication and hospital readmission rates when HARMONIC Shears were used across pediatric and adult ENT procedures, including neck dissection, glossectomy, laryngectomy, pharyngectomy, tonsillectomy, parathyroid, thyroidectomy and adenoidectomy. The addition of ENT indications further strengthens Johnson & Johnson MedTech’s surgical energy portfolio and commitment to supporting clinicians across a wider range of procedures.
“This FDA clearance marks an important step in expanding access to HARMONIC™ technology for ENT procedures showcasing Johnson & Johnson’s commitment to serving the specialty, which represents approximately 5.5 million surgical procedures annually within the U.S. Supported by real-world evidence, the expanded indication reinforces our commitment to developing innovations that address the evolving needs of surgeons and the patients they serve,” said Sandeep Makkar, Worldwide President, Endomechanical and Energy, MedTech, Johnson & Johnson.
About Surgical Solutions from Johnson & Johnson MedTech
Across Johnson & Johnson, we are tackling the world’s most complex and pervasive health challenges. For over 100 years, we have helped advance surgical care through our innovative portfolio across wound closure, adjunctive hemostats, surgical stapling and instruments, robotics and digital solutions. Together, with clinicians and healthcare experts around the world we are progressing what’s next in surgery to better solve patient needs in metabolic and cardiovascular disease, cancer, and aesthetics and reconstruction.
About Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector’s global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at jnjmedtech.com.
Follow us at @JNJMedTech and on LinkedIn. Ethicon, Inc. is part of Johnson & Johnson MedTech.
Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the HARMONIC™ 1100 Shears. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: competition, including technological advances, new products and patents attained by competitors; uncertainty of commercial success for new products; the ability of the company to successfully execute strategic plans; impact of business combinations and divestitures; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; and global health care reforms and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s most recent Annual Report on Form 10-K, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments.
Footnotes:
*Based on user validation study where 14/19 surgeons that use competitive advanced energy devices rated Harmonic 1100 Shear as superior in dissection capability.
†Device measurements based on a metrology study compared to HARMONIC ACE™+7.
References:
1. HARMONIC ACE 5mm Diameter Shears + Adaptive Tissue Technology Instructions for Use
2. HARMONIC Synergy Dissecting Hook, Curved Blade with Torque Wrench Instructions for Use
3. HARMONIC ACE+7, 5mm Diameter Shears with Advanced Hemostasis Instructions for Use
4. HARMONIC 1100 Shears Instructions for Use
5. Harmonic HD 1000i Shears Instructions for Use
6. Harmonic FOCUS Curved Shears with Torque Wrench with Grip Assist Instructions for Use
7. Johnson & Johnson and its affiliates, Project Gemini (Harmonic 700) - Thermal Spread Equivalency Memo. 06/09/2022. Windchill Document #500989271
8. Ethicon, Buccaneer Validation Marketing Questions. 05/16/2016. Windchill Document #DOC021988
9. Ethicon, Harmonic HD 1000i Open Shears (HARHD20) and Harmonic HD 1000i Laparoscopic Shears (HARHD36): Design Verification Acute Study in the Pig. 10/26/2016. Windchill Document #PSP004888
10. Ethicon, HARMONIC HD 1000i Competitive Overlays. 03/18/2016. Internal Document
11. Ethicon, Scarlet Witch Physical Equivalence Memo. 04/13/2020. Windchill Document #SCN075090
12. Ethicon, Project Scarlet Design Validation Completion Report. 02/05/2021. Windchill Document #PRC094018
13. Ethicon, Buccaneer Metrology Claims. 03/29/2016. Windchill Document #PRC074607
For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference full package insert.
Media Contact:
Lindsey Diaz-MacInnis
ldiazmac@its.jnj.com